Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity

por Tundidor, Yaima, Ponce, Luis F., Chao, Lisset, Solozábal, Joaquín, Hust, Michael, Dübel, Stefan, Rojas, Gertrudis
Publicado 2020

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

por Garrido, Greta, Rabasa, Ailem, Garrido, Cristina, Chao, Lisset, Garrido, Federico, García-Lora, Ángel M., Sánchez-Ramírez, Belinda
Publicado 2017